Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Archana Vijaya Kumar; Carmen Donate; Beat A. Imhof; Thomas Matthes

doi:10.3791/56023

Tumor Engraftment in einem Xenograft-Maus-Modell der menschlichen Mantel-Zell-Lymphom

JoVE Journal
Cancer Research

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Cancer Research

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in einem Xenograft-Maus-Modell der menschlichen Mantel-Zell-Lymphom

Full Text

11,725 Views

10:52 min

March 30, 2018

DOI: 10.3791/56023-v

Archana Vijaya Kumar^1,2, Carmen Donate², Beat A. Imhof¹, Thomas Matthes²

¹Department of Pathology and Immunology,University of Geneva, ²Hematology Service,University Hospital, Geneva

Please note that some of the translations on this page are AI generated. Click here for the English version.

Overview

This article discusses the establishment of a xenograft mouse model for mantle cell lymphoma (MCL), a challenging B cell disorder. The model aims to facilitate the study of MCL biology and the development of therapeutic strategies.

Key Study Components

Area of Science

Hematooncology
Xenograft models
Therapeutic development

Background

Mantle cell lymphoma is difficult to treat.
Establishing xenograft models for MCL is challenging.
Understanding MCL biology is crucial for developing therapies.
Patient-derived xenografts can provide insights into treatment responses.

Purpose of Study

To establish a xenograft model for MCL.
To develop treatment strategies for MCL.
To study the therapeutic outcomes of various treatment approaches.

Methods Used

Establishment of xenografts in mice.
In vivo studies of drug effects on human lymphoma cells.
Utilization of patient-derived cells for therapy assessment.
Application of the model to various lymphoma types.

Main Results

Successful establishment of MCL xenografts in mice.
Insights into the therapeutic effects of treatments on MCL.
Feasibility of studying patient-derived cells in vivo.
Potential application of the model to other lymphoma types.

Conclusions

The xenograft model is a valuable tool for MCL research.
It aids in understanding therapeutic responses in MCL.
This method can be adapted for studying various lymphomas.

Frequently Asked Questions

What is mantle cell lymphoma?

Mantle cell lymphoma is a type of B cell lymphoma that is challenging to treat.

Why are xenograft models important?

Xenograft models allow researchers to study human cancer cells in a living organism, providing insights into treatment effects.

What are patient-derived xenografts?

Patient-derived xenografts are models created by implanting human tumor cells into mice, allowing for personalized treatment studies.

How can this model help in therapy development?

The model helps researchers evaluate the effectiveness of different treatment strategies on human lymphoma cells.

Can this method be applied to other types of lymphomas?

Yes, the xenograft model can be adapted to study various lymphoma types beyond mantle cell lymphoma.

What challenges exist in obtaining patient-derived xenografts?

Obtaining patient-derived xenografts can be difficult due to the need for viable tumor samples and the complexity of the procedure.

Mantel-Zell-Lymphom (MCL) ist ein schwer zu B-Zell-Störung zu behandeln, und es ist ebenso schwierig, zur Einrichtung eines Xenograft-Maus-Modell der primären MCL zu studieren und Therapeutika zu entwickeln. Hier beschreiben wir die erfolgreiche Etablierung von MCL Xenotransplantate bei Mäusen zu helfen, die zugrunde liegende Biologie zu verstehen.

Das übergeordnete Ziel dieser Methode ist es, ein Xenotransplantat-Mausmodell für das Mantelzell-Lymphom zu etablieren, um Behandlungsstrategien für diese Erkrankung zu entwickeln. Diese Methode kann helfen, zentrale Fragen im Bereich der Hämatoonkologie zu beantworten, wie z.B. das therapeutische Ergebnis verschiedener Behandlungsstrategien. Der Hauptvorteil dieser Technik besteht darin, dass sie es uns ermöglicht, die Wirkung von Medikamenten auf menschliche Lymphomzellen in vivo zu untersuchen.

Die Implikationen dieser Technik erstrecken sich auf die Therapie des Mantelzell-Lymphoms, da es mit diesem Modell nicht nur machbar, sondern auch bequem ist, die Wirkung der Therapie auf patientengewonnene Zellen zu untersuchen. Obwohl diese Methode Einblicke in therapeutische Aspekte des Mantelzell-Lymphoms geben kann, kann sie auch zur Untersuchung verschiedener Arten von Lymphomen eingesetzt werden. Im Allgemeinen werden Personen, die mit dieser Methode noch nicht vertraut sind, Schwierigkeiten haben, da es schwierig ist, von Patienten stammende Xenotransplantate zu erhalten.

View the full transcript and gain access to thousands of scientific videos

Explore More Videos

Cancer Research Ausgabe 133 Mantel Zell-Lymphom B-Zellen Xenograft Modell Homing Tumors Engraftment Therapeutika